Utah Retirement Systems’s Agios Pharmaceuticals AGIO Stock Holding History

Utah Retirement Systems’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,678	Closed	-$483K	–	957
2019 Q2	$483K	Buy	9,678 +186	+2%	+$9.94K	0.01%	917
2019 Q1	$641K	Buy	9,492 +92	+1%	+$5.36K	0.01%	863
2018 Q4	$434K	Hold	9,400	–	–	0.01%	904
2018 Q3	$725K	Hold	9,400	–	–	0.01%	853
2018 Q2	$792K	Buy	9,400 +200	+2%	+$17.4K	0.02%	824
2018 Q1	$753K	Buy	9,200 +1,500	+19%	+$116K	0.02%	805
2017 Q4	$440K	Buy	7,700 +100	+1%	+$6.29K	0.01%	927
2017 Q3	$507K	Hold	7,600	–	–	0.01%	901
2017 Q2	$391K	Buy	7,600 +2,000	+36%	+$102K	0.01%	946
2017 Q1	$327K	Hold	5,600	–	–	0.01%	937
2016 Q4	$234K	Buy	5,600 +100	+2%	+$5.25K	0.01%	963
2016 Q3	$290K	Buy	5,500 +400	+8%	+$17.4K	0.01%	956
2016 Q2	$214K	Buy	+5,100	New	+$252K	0.01%	980
2016 Q1	–	Sell	-4,600	Closed	-$299K	–	1002
2015 Q4	$299K	Hold	4,600	–	–	0.01%	956
2015 Q3	$325K	Hold	4,600	–	–	0.01%	958
2015 Q2	$511K	Buy	+4,600	New	+$495K	0.01%	909

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Utah Retirement Systems's AGIO Position: Q3 2019 in Review

Utah Retirement Systems sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 9,678 shares — an estimated $483K sold.

Utah Retirement Systems first reported a position in AGIO in Q2 2015 and held it in 16 quarters. The position peaked at $792K in Q2 2018. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

Utah Retirement Systems reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Utah Retirement Systems sold 9,678 Agios Pharmaceuticals shares in Q3 2019, an estimated $483K.
Utah Retirement Systems first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 16 quarters.
Utah Retirement Systems's Agios Pharmaceuticals position peaked at $792K in Q2 2018.
189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Utah Retirement Systems's 13F filing for Q3 2019, filed 14 Nov 2019.